SEC Form 4 · accession 0001628656-17-000002
MYRIAD GENETICS INC · MYGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bernard Tobin
Officer — President Crescendo BioScience
Period of report
Jan 3, 2017
Accepted (ET)
Jan 4, 2017 · 1:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 3, 2017 | D | 2,631 | $16.93 | D | 116,360 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.